Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, today published a new study explaining how they took a protein once thought to be too challenging for targeted therapy, proliferating cell nuclear antigen (PCNA), and developed a targeted chemotherapy that appears to annihilate all solid tumors in preclinical research.
Pfizer says IRA impact will be ‘modest,’ maps out R&D priority changes
Despite being an early critic of the Inflation Reduction Act, Pfizer told investors on Monday that the legislation is likely to have a “modest” impact
March 6, 2024